Concepedia

Publication | Closed Access

Exploration of the Effect and Mechanism of ShenQi Compound in a Spontaneous Diabetic Rat Model

DOI

23

Citations

0

References

2019

Year

Ya Liu, Jian Kang, Hong Gao, Xiyu Zhang, Jun Chao, Gong Guang-ming, Haipo Yuan, Chunguang Xie
Endocrine Metabolic & Immune Disorders - Drug Targets

Abstract

All these results indicate that SQC is an effective therapeutic drug on T2DM. Notably, SQC presents an obvious blood glucose fluctuation-preventing ability, which might be derived from the regulation of the mTOR signaling pathway.